AcelRx Pharma (ACRX) Misses Q3 EPS by 2c

AcelRx Pharma (NASDAQ: ACRX) reported Q3 EPS of ($0.25), $0.02 worse than the analyst estimate of ($0.23). Revenue for the quarter came in at $1.6 million versus the consensus estimate of $2.89 million.

For earnings history and earnings-related data on AcelRx Pharma (ACRX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
• Movano (MOVE) Misses Q2 EPS by 195c